“If this blog helped you out, don’t keep it to yourself—share the link on your socials!” 👍 “Like what you read? Spread the love and share this blog on your social media.” 👍 “Found this useful? Hit share and let your friends know too!” 👍 “If you enjoyed this post, please share the URL with your friends online.” 👍 “Sharing is caring—drop this link on your social media if it helped you.”

Saturday, August 30, 2025

Anchen Pharmaceuticals


Anchen Pharmaceuticals’ products

Desvenlafaxine extended-release tablets (75 mg)
Indication: Depression—mid-range strength, extended-release dosage

Desvenlafaxine extended-release tablets (150 mg)
Indication: Depression—higher strength for once-daily extended-release administration

Venlafaxine hydrochloride extended-release capsules (37.5 mg base equivalent)
Indication: Depression—low-dose extended-release formulation

Venlafaxine hydrochloride extended-release capsules (75 mg base equivalent)
Indication: Depression—moderate-dose extended-release formulation

Venlafaxine hydrochloride extended-release capsules (150 mg base equivalent)
Indication: Depression—higher-dose extended-release formulation



on

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)